Black Rock Inc. Minerva Neurosciences, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Minerva Neurosciences, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 72,669 shares of NERV stock, worth $162,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,669
Previous 72,669
-0.0%
Holding current value
$162,778
Previous $187,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NERV
# of Institutions
21Shares Held
2.12MCall Options Held
0Put Options Held
0-
Federated Hermes, Inc. Pittsburgh, PA1.35MShares$3.03 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA252KShares$564,6140.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny157KShares$352,1280.0% of portfolio
-
Ubs Oconnor LLC Chicago, IL107KShares$240,2530.02% of portfolio
-
Geode Capital Management, LLC Boston, MA56.5KShares$126,4610.0% of portfolio
About Minerva Neurosciences, Inc.
- Ticker NERV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,340,190
- Market Cap $12M
- Description
- Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...